Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01492842 · ClinicalTrials.gov registry record

Correlates of Oral Human Papillomavirus Infection in Adolescents and Young Adults With Behaviorally Acquired HIV

A clinical trial, sponsored by University of North Carolina, Chapel Hill.

Completed
Registry status
272
Enrollment target

NCT01492842 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 272 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01492842 has completed, sponsored by University of North Carolina, Chapel Hill.

COMPLETED
Registry status
272 participants
Enrollment target

Study Summary

The proposed study is a substudy of ATN 106 and a cross sectional study intended to be conducted at each of the AMTUs newly participating in ATN III. The intent is to enroll all youth with behaviorally-acquired HIV who have enrolled in ATN 106. The study involves a review of the subjects' medical chart and a collection of an oral rinse sample.

Trial Details

FieldValue
Enrollment Target 272 participants
Start Date 2011-09
Est. Completion 2012-06

What the Registry Record Tells You About NCT01492842

The ClinicalTrials.gov registry entry for NCT01492842 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 272 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01492842 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01492842 about?

NCT01492842 is a clinical study titled "Correlates of Oral Human Papillomavirus Infection in Adolescents and Young Adults With Behaviorally Acquired HIV". The proposed study is a substudy of ATN 106 and a cross sectional study intended to be conducted at each of the AMTUs newly participating in ATN III. The intent is to enroll all youth with behaviorally-acquired HIV who have enrolled in ATN 106. The study involves a review of the subjects' medical ch...

What is the current status of trial NCT01492842?

This trial is currently completed. The enrollment target is 272 participants. The study started on 2011-09. Estimated completion is 2012-06.

Who is sponsoring clinical trial NCT01492842?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.